Streetbeat News

Stock Prices

FSR

GOEV

LCID

RIVN

TSLA

VLCN

Shares of electric vehicle (EV) stocks are experiencing an uptick following a report by CleanTechnica that indicated a 29% increase in Q4 sales of pure electric vehicles.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 7:54 pm

Zoom Video Comms Inc. (NASDAQ:ZM) has seen a slight drop in its stock price in the current session and has experienced declines over the past month and year. Investors are examining the company's P/E ratio, which is lower than the Software industry average, suggesting that the stock might be undervalued or that shareholders have low growth expectations.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 7:30 pm

AMD

MCHP

QCOM

QRVO

SLAB

SWKS

The semiconductor industry is experiencing mixed Q4 earnings results, with KeyBanc Capital Markets providing insights and ratings for six companies reporting in the upcoming week: AMD, MCHP, QRVO, QCOM, SLAB, and SWKS. Texas Instruments and Intel reported lower-than-expected results and guidance, while optimism remains for AMD, and solid results are expected for smartphone semiconductor companies. The IoT sector, represented by SLAB, is anticipated to show gradual recovery.

Portfolio Pulse from Surbhi Jain

January 29, 2024 | 7:27 pm

BFRG

CDLX

PBLA

SNCE

SOFI

U.S. stocks saw a slight increase, with the Nasdaq Composite up by 75 points. The Dow and S&P 500 also experienced modest gains. Consumer discretionary shares led the gains, while energy shares declined following a 1.3% drop in crude oil prices. Science 37 Holdings (SNCE) surged 16% after agreeing to be acquired by eMed. SoFi Technologies (SOFI) jumped 16% on strong quarterly revenue, and Cardlytics (CDLX) rose 28% after a settlement agreement and updated Q4 results. Conversely, Panbela Therapeutics (PBLA) plummeted 67% due to a public offering, Bullfrog AI Holdings (BFRG) fell 24% after a shelf offering, and Bloom Energy (BE) dropped 7% after a downgrade by B of A Securities. The Federal Reserve Bank of Dallas reported a decline in Texas manufacturing activity.

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 7:24 pm

PBLA

Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares plummeted by 65.5% to $1.47 after announcing a public offering priced at approximately $9 million. Other stocks experienced significant movements in Monday's mid-day session, with various companies showing notable gains and losses. Gainers included Palisade Bio, Inc. (NASDAQ:PALI), OneMedNet Corporation (NASDAQ:ONMD), and Revelation Biosciences, Inc. (NASDAQ:REVB), among others. Losers featured SMX (Security Matters) Public Limited Company (NYSE:SMX), Inspire Veterinary Partners, Inc. (NASDAQ:IVP), and Bullfrog AI Holdings, Inc. (NASDAQ:BFRG), among others.

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 7:09 pm

HARP

MRK

Merck & Co Inc (MRK) is experiencing a stock rally ahead of its Q4 earnings report, driven by optimism around its cancer drug Keytruda, which has received four FDA approvals since November 2023. The latest approval on Jan. 12 allows Keytruda to be used with chemoradiotherapy for certain cervical cancers. Merck's stock has also been positively influenced by the acquisition of Harpoon Therapeutics Inc (HARP) for $680 million, aimed at enhancing its cancer treatment pipeline. A technical indicator, the Golden Cross, has occurred for Merck stock, suggesting continued upward momentum.

Portfolio Pulse from Surbhi Jain

January 29, 2024 | 7:05 pm

ABBV

CERE

IMGN

William Blair has upgraded AbbVie Inc (NYSE:ABBV) from Market Perform to Outperform, citing confidence in the company's growth prospects into 2024 despite competitive pressures. AbbVie's growth is attributed to strong performance by Skyrizi and Rinvoq, strategic acquisitions of ImmunoGen Inc (NASDAQ:IMGN) and Cerevel Therapeutics Holdings Inc (NASDAQ:CERE), and the highest dividend yield among peers. AbbVie faces competition for Humira, Imbruvica, and Botox but is expected to sustain growth. Q4 2023 earnings are anticipated on February 2, with an expected EPS of $2.81 and sales of $14.03 billion.

Portfolio Pulse from Vandana Singh

January 29, 2024 | 7:04 pm

TIAUSD

Celestia's cryptocurrency (CRYPTO: TIA) price has increased by 4.44% in the last 24 hours, reaching $17.76, continuing a 14% weekly gain. Despite a 16% drop in trading volume over the week, the circulating supply increased by 1.05% to 160.77 million. Celestia's market cap is now $2.85 billion, ranking it 33rd.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 7:03 pm

AMZN

GOOGL